Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    SNIFF-120
Show Display Options
Rank Status Study
1 Completed SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: Regular Insulin;   Drug: Placebo
2 Active, not recruiting The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: Insulin (Humulin® R U-100);   Drug: Placebo
3 Unknown  A Study of the Effects of Sodium Citrate on Olfactory Thresholds
Condition: Anosmic and Hyposmic Patients

Indicates status has not been verified in more than two years